Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Acura Pharmaceuticals ( (ACUR) ) has issued an announcement.
On June 28, 2019, Acura Pharmaceuticals entered into a $6.0 million promissory note with John Schutte, which was later transferred to AD Pharma. By June 9, 2021, AD Pharma converted the note and accrued interest into 42,984,375 shares of Acura’s common stock. As of May 29, 2025, AD Pharma owns approximately 65% of Acura’s outstanding common stock, excluding a warrant for 10 million shares. The maturity date of a secured promissory note was extended to December 31, 2025, reflecting strategic financial adjustments.
More about Acura Pharmaceuticals
Average Trading Volume: 8,025
Technical Sentiment Signal: Sell
Current Market Cap: $1.32M
For detailed information about ACUR stock, go to TipRanks’ Stock Analysis page.